Department of Pediatrics, Abuzar Children's Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Iran J Immunol. 2020 Dec;17(4):333-340. doi: 10.22034/iji.2020.83003.1607.
Combined immunodeficiencies (CIDs) are a heterogeneous group of disorders characterized by various gene mutations. The mutations in the STK4 (Serine Threonine Kinase 4) gene, which has a role in the regulation of apoptosis and proliferation, can be a cause of immunodeficiency. In the current paper, we reported a case of identical twin brothers with a novel STK4 mutation, one of whom showed clinical manifestations associated with this mutation with a delay of two years. The mutation in the STK4 gene was identified employing Whole Exome Sequencing (WES), and we described the probable reasons for this delay. We found that the STK4 genetic defect caused almost the same clinical symptoms of immunodeficiency in the twin brothers. Meanwhile, the severity of the disease was higher in one of them, which may be due to extra genetic defect in LRBA, and likely differences in the percentage of B lymphocyte population and CD4+/ CD8+ state.
联合免疫缺陷症(CIDs)是一组具有多种基因突变特征的异质性疾病。在调节细胞凋亡和增殖中发挥作用的 STK4(丝氨酸苏氨酸激酶 4)基因突变可能导致免疫缺陷。在本研究中,我们报道了一对患有新型 STK4 基因突变的同卵双胞胎兄弟的病例,其中一个兄弟出现了与该突变相关的临床表现,延迟了两年。采用外显子组测序(WES)对 STK4 基因的突变进行了鉴定,并描述了这种延迟的可能原因。我们发现 STK4 基因缺陷在这对双胞胎兄弟中引起了几乎相同的免疫缺陷临床表现。同时,其中一个兄弟的疾病严重程度更高,这可能是由于 LRBA 中存在额外的遗传缺陷,以及 B 淋巴细胞群体和 CD4+/CD8+状态的百分比可能存在差异所致。